oxford news : Latest oxford News At True Scoop 

oxford News Today : Get All latest  oxford News And Updates On True Scoop News. Read Politics News, Current Affairs  And News Headlines On  oxford News Today.

Recommendations to be made to revoke their license for covid care facilities if plants not set up: DC Ghanshyam Thori

Jalandhar administration issues show-cause notices to 7 private hospitals for not installing oxygen plants

Recently, the CEO of Serum Institute of India (SII) Adar Poonawala has opened up in an interview with a British media channel and said that he is receiving threat calls from powerful men.

'Receiving threats calls, I can't comment on Kumbh and Elections', says Adar Ponnawala

The letter signed by the Chief Investigator, Andrew J Pollard, Oxford Professor, of the trail and sent to the trial subjects on June 8 show that the researches wanted to learn the efficacy of vaccine at different doses.

Oxford Astra-Zeneca Vaccine: Volunteers kept in dark over wrong dose

While Covaxin is an indigenous vaccine prepared by Hyderabad based Bharat Biotech, Covishield is prepared by Serum Institue of India that is an equivalent of Oxford-Astrazeneca vaccine.

India pauses Covishield export by SII until April, distribution priority in region

Clinical trials are also being conducted in the US, Japan, Russia, South Africa, Kenya, and Latin America

Oxford AstraZeneca vaccine prevents an average of 70% Covid-19 cases

The SII received approval by the India's top drug regulator on Sunday after a thorough evaluation based on the recommendations of the Subject Expert Committee on COVID-19.

News

Jalandhar administration issues show-cause notices to 7 private hospitals for not installing oxygen plants

'Receiving threats calls, I can't comment on Kumbh and Elections', says Adar Ponnawala

Oxford Astra-Zeneca Vaccine: Volunteers kept in dark over wrong dose

India pauses Covishield export by SII until April, distribution priority in region

Oxford AstraZeneca vaccine prevents an average of 70% Covid-19 cases

DCGI approves SII's clinical trials of Oxford vaccine